If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Mounjaro is the brand name for tirzepatide, and research shows that people with overweight and obesity have lost up to 25% of their body weight on this medication. Social media users have latched onto ...

Mounjaro (tirzepatide) is a brand-name drug prescribed ... Mounjaro comes as a solution in a single-dose pen. You’ll administer Mounjaro weekly as a subcutaneous injection.

Today we've published final guidance for the weight loss medication tirzepatide (mounjaro). It means the phased roll out – set out in our guidance – will begin in 2025. In 2022, the government ...

Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the ...

We continued to make progress on our manufacturing build-out, and U.S. supply across all doses of tirzepatide was available throughout Q4," said Lilly CEO David Ricks in a statement. The move in ...